000 | 01929 a2200505 4500 | ||
---|---|---|---|
005 | 20250516160741.0 | ||
264 | 0 | _c20131126 | |
008 | 201311s 0 0 eng d | ||
022 | _a1083-351X | ||
024 | 7 |
_a10.1074/jbc.M112.445148 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDai, Chun-Ling | |
245 | 0 | 0 |
_aInhibition of protein synthesis alters protein degradation through activation of protein kinase B (AKT). _h[electronic resource] |
260 |
_bThe Journal of biological chemistry _cAug 2013 |
||
300 |
_a23875-83 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aChromones |
650 | 0 | 4 |
_aCycloheximide _xpharmacology |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 | _aHEK293 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMorpholines |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aProtein Biosynthesis _xdrug effects |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
650 | 0 | 4 |
_aProtein Synthesis Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProteolysis _xdrug effects |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-mdm2 _xmetabolism |
650 | 0 | 4 | _aPyruvate Dehydrogenase Acetyl-Transferring Kinase |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aSirolimus _xpharmacology |
650 | 0 | 4 |
_aSubstrate Specificity _xdrug effects |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
700 | 1 | _aShi, Jianhua | |
700 | 1 | _aChen, Yanxing | |
700 | 1 | _aIqbal, Khalid | |
700 | 1 | _aLiu, Fei | |
700 | 1 | _aGong, Cheng-Xin | |
773 | 0 |
_tThe Journal of biological chemistry _gvol. 288 _gno. 33 _gp. 23875-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M112.445148 _zAvailable from publisher's website |
999 |
_c22907766 _d22907766 |